ARFIM
Institut Bergonié
Institut Bergonié
Accent Therapeutics
Inspirna, Inc.
Mirati Therapeutics Inc.
Baylor Research Institute
Pheon Therapeutics
Novartis
Takeda
Tempus AI
NuCana plc
Institut Bergonié
Eli Lilly and Company
Weill Medical College of Cornell University
Swiss Cancer Institute
Black Diamond Therapeutics, Inc.
Mirati Therapeutics Inc.
University of Iowa
Washington University School of Medicine
Peter MacCallum Cancer Centre, Australia
Mayo Clinic
Alliance for Clinical Trials in Oncology
Mirati Therapeutics Inc.
University of Kentucky
NantCell, Inc.
NextCure, Inc.
Columbia University
Ohio State University Comprehensive Cancer Center
ADC Therapeutics S.A.
Columbia University
Abramson Cancer Center at Penn Medicine
Milton S. Hershey Medical Center
HiberCell, Inc.
Virginia Commonwealth University
Gilead Sciences
Stanford University
National Cancer Institute (NCI)
Ludwig Institute for Cancer Research
pharmaand GmbH
NSABP Foundation Inc
Roswell Park Cancer Institute
Eastern Cooperative Oncology Group
Eisai Inc.
Masonic Cancer Center, University of Minnesota
Northwell Health
Brown University
University of California, San Francisco
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Imunon
Royal Marsden NHS Foundation Trust
Fred Hutchinson Cancer Center